The study of the quality characteristics for the choice of cardiological drugs of plant origin
DOI:
https://doi.org/10.24959/sphhcj.18.115Keywords:
cardiological drugs, cardiovascular diseases, questionnaires, expert evaluationAbstract
Aim. To study the assessment of the nomenclature of medicinal products in order to make it possible to select drugs that are most often prescribed by doctors from the whole range of herbal drugs, as well as to identify the nomenclature of ineffective and undesirable to use herbal drugs.
Materials and methods. In accordance with the objectives of the expert evaluation, as well the possibilities of the research, the method of questioning was chosen. It allows explaining the essence of the issues to the experts, providing more thoughtful responses to obtain reliable information about the nomenclature of herbal drugs, their functional properties and competitiveness.
Results. According to the majority of respondents-doctors (59.1 %) the future of pharmacotherapy is in the concurrent administration of synthetic drugs and herbal drugs for the treatment of cardiovascular diseases (CVD). According to the pharmaceutical workers the most important properties of herbal drugs affecting their prescription are the cost of the drug (95.3 %), the effectiveness of the use (80.5 %), the country of manufacture (70.6 %), side effects (60.9 %), the product form and dose (35.6 %), way of administration (26.8 %). It has been determined that the majority of cardiologists (59 % of the respondents) prefer to receive information about herbal drugs from the materials of scientific conferences, as well as reviews and scientific articles containing the results of clinical trials of herbal drugs (63 % of the respondents).
Conclusions. Based on the analysis of the studies it has been determined that it is necessary to carry out the career guidance work among medical personnel for providing information on the latest herbal drugs and methods of treatment, work with patients on informing about prevention of development of the cardiovascular diseases.
References
Sakhanda, I. V., Nehoda, T. S., Siatynia, M. L. (2015). Proceeding from Modern medicine: topical issues: International scientific–practical conference (pp. 12–13). Odesa.
Batoieva, B. G. (2012). Proceeding from Chelovek i lekarstvo: tez. dokl. Rossiiskogo Natcionalnogo kongressa (p. 497). Moscow.
Sakhanda, I. V., Nehoda, T. S., Siatynia, M. L. (2015). Liky Ukrainy plius, 4 (25), 116–118.
Sakhanda, I. V., Nehoda, T. S., Siatynia, M. L. (2016). Proceeding from Naukovo–tekhnichnyi prohres i optymizatsiia tekhnolohichnykh protsesiv stvorennia likarskykh prepartiv: materialy VI nauk.–prakt. konf. z mizh nar. uchastiu (10–11 lystopada 2016) (pp. 118–120). Ternopil.
Kondrashkov, N. G.,Kulik, V. V., Kabakov, T. I. (2014). Novaia Apteka, 5, 23–26.
Dremova, N. B., Lazarev, E. V. (2016). Farmatsiia, 45 (1), 27–29.
Siatynia, M. L., Nehoda, T. S., Sakhanda, I. V. (2015). The study of the motivations and preferences of consumers when choosing herbal medicines for treating cardiovascular diseases. Ukrainian Scientific Medical Youth Journal, 4 (91), 120–123.
Dremova, N. B., Kobzar, L. V. (2014). Farmatsiia, 1, 12–16.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
